Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Barnes

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Gynecologic Oncology|October 19, 2001
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervixW K Huh, J Gomez-Navarro, W O Arafat, et al.
Gene Therapy|March 5, 2004
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapyH Wu, T Han, J T Lam, et al.
Gynecologic Oncology|September 5, 2001
Transcriptional targeting for ovarian cancer gene therapyE Casado, D M Nettelbeck, J Gomez-Navarro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral-mediated suicide gene therapy for ovarian cancerR D Alvarez, J Gomez-Navarro, M Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancerW O Arafat, J Gómez-Navarro, J Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinomaP J Mahasreshti, J G Navarro, M Kataram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trialR D Alvarez, M N Barnes, J Gomez-Navarro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Gene Therapy|March 16, 2002
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFvW O Arafat, J Gómez-Navarro, D J Buchsbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applicationsE Casado, J Gomez-Navarro, M Yamamoto, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Gynecologic Oncology|October 19, 2001
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervixW K Huh, J Gomez-Navarro, W O Arafat, et al.
Gene Therapy|March 5, 2004
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapyH Wu, T Han, J T Lam, et al.
Gynecologic Oncology|September 5, 2001
Transcriptional targeting for ovarian cancer gene therapyE Casado, D M Nettelbeck, J Gomez-Navarro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000
Adenoviral-mediated suicide gene therapy for ovarian cancerR D Alvarez, J Gomez-Navarro, M Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancerW O Arafat, J Gómez-Navarro, J Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinomaP J Mahasreshti, J G Navarro, M Kataram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trialR D Alvarez, M N Barnes, J Gomez-Navarro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expressionA Hemminki, N Belousova, K R Zinn, et al.
Gene Therapy|March 16, 2002
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFvW O Arafat, J Gómez-Navarro, D J Buchsbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applicationsE Casado, J Gomez-Navarro, M Yamamoto, et al.
Pageof 3